- Home
- MEDP
as 09-02-2025 4:00pm EST
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 13.4B | IPO Year: | 2016 |
| Target Price: | $406.89 | AVG Volume (30 days): | 329.2K |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 13.46 | EPS Growth: | 26.42 |
| 52 Week Low/High: | $250.05 - $501.30 | Next Earning Date: | 10-20-2025 |
| Revenue: | $2,231,787,000 | Revenue Growth: | 9.94% |
| Revenue Growth (this year): | 19.01% | Revenue Growth (next year): | 8.88% |
Stock Insider Trading Activity of Medpace Holdings Inc. (MEDP)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Troendle August J. | MEDP | CEO | Aug 27 '25 | Sell | $475.00 | 620 | $294,500.00 | 961,995 | |
| McCarthy Cornelius P. III | MEDP | N/A | Aug 19 '25 | Sell | $465.04 | 1,662 | $772,896.48 | 10,197 |
Latest Medpace Holdings Inc. News
MEDP Breaking Stock News: Dive into MEDP Ticker-Specific Updates for Smart Investing
StockStory
12 days ago
2 Reasons to Watch MEDP and 1 to Stay Cautious
Investor's Business Daily
14 days ago
Health Care Stock Flashes Golden Cross As Sales Surge; Shares Hover Near Buy Point
Zacks
14 days ago
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
Zacks
2 months ago
Medpace (MEDP) Stock Dips While Market Gains: Key Facts
StockStory
2 months ago
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
Argus Research
2 months ago
MEDP: Raising target price to $331.00
MT Newswires
2 months ago
Barclays Initiates Coverage on Medpace With Equal Weight Rating, $300 Price Target
Business Wire
2 months ago
Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025
Compare MEDP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MEDP Medpace Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.